These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23903338)

  • 21. Bipolar disorder and metabolic syndrome: comorbidity or side effects of treatment of bipolar disorder.
    Babić D; Maslov B; Martinac M; Nikolić K; Uzun S; Kozumplik O
    Psychiatr Danub; 2010 Mar; 22(1):75-8. PubMed ID: 20305595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bipolar disorder and somatic comorbidity].
    Corruble E
    Encephale; 2008 Jun; 34 Suppl 4():S143-5. PubMed ID: 18707937
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of metabolic syndrome prevalence in patients with schizophrenia and bipolar I disorder.
    Nayerifard R; Bureng MA; Zahiroddin A; Namjoo M; Rajezi S
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S411-S416. PubMed ID: 28927969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bipolar disorder and metabolic syndrome: an international perspective.
    McIntyre RS; Danilewitz M; Liauw SS; Kemp DE; Nguyen HT; Kahn LS; Kucyi A; Soczynska JK; Woldeyohannes HO; Lachowski A; Kim B; Nathanson J; Alsuwaidan M; Taylor VH
    J Affect Disord; 2010 Nov; 126(3):366-87. PubMed ID: 20541810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of bipolar disorders and metabolic syndrome: implications for primary care.
    Bell PF; McKenna JP; Roscoe BM
    Postgrad Med; 2009 Sep; 121(5):140-4. PubMed ID: 19820282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of prevalence of metabolic syndrome in bipolar disorder and schizophrenia from North India.
    Grover S; Nebhinani N; Chakrabarti S; Avasthi A; Kulhara P; Basu D; Mattoo SK; Malhotra S
    Nord J Psychiatry; 2014 Jan; 68(1):72-7. PubMed ID: 23293896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome in patients with bipolar disorder.
    Fagiolini A; Frank E; Turkin S; Houck PR; Soreca I; Kupfer DJ
    J Clin Psychiatry; 2008 Apr; 69(4):678-9. PubMed ID: 18507490
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence of the metabolic syndrome in veterans with schizophrenia.
    Meyer J; Loh C; Leckband SG; Boyd JA; Wirshing WC; Pierre JM; Wirshing D
    J Psychiatr Pract; 2006 Jan; 12(1):5-10. PubMed ID: 16432440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Six months' course and outcome of metabolic abnormalities in a cohort of patients with schizophrenia in rural India.
    Bijjal S; Ganesh S; Rawat VS; Agarwal V; Shanivaram Reddy K; Renuka Devi NR; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Nov; 201():415-416. PubMed ID: 29880456
    [No Abstract]   [Full Text] [Related]  

  • 30. Seasonal and temperamental contributions in patients with bipolar disorder and metabolic syndrome.
    McIntyre RS
    Braz J Psychiatry; 2013; 35(2):210. PubMed ID: 23904030
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
    van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    Bipolar Disord; 2008 Mar; 10(2):342-8. PubMed ID: 18271914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of bipolar disorder with antipsychotic medication: issues shared with schizophrenia.
    Young AH
    J Clin Psychiatry; 2007; 68 Suppl 6():24-5. PubMed ID: 17650056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
    Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
    Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic drugs and metabolic syndrome--can we prevent it?
    Reis AF
    Braz J Psychiatry; 2007 Mar; 29(1):9-10. PubMed ID: 17435920
    [No Abstract]   [Full Text] [Related]  

  • 36. Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey.
    McIntyre RS
    J Clin Psychiatry; 2009; 70 Suppl 3():5-11. PubMed ID: 19570496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar Disorder.
    Brooks JO; Goldberg JF; Ketter TA; Miklowitz DJ; Calabrese JR; Bowden CL; Thase ME
    J Clin Psychiatry; 2011 Feb; 72(2):240-7. PubMed ID: 20868629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risk factors among forensic patients in the acute psychiatric ward.
    Sazhin V; Reznik R
    Aust N Z J Psychiatry; 2008 Mar; 42(3):254. PubMed ID: 18247202
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolic Syndrome at an Outpatient Clinic for Bipolar Disorders: A Case for Systematic Somatic Monitoring.
    Simoons M; Mulder H; Doornbos B; Raats PCC; Bruggeman R; Cath DC; Schoevers RA; Ruhé HG; van Roon EN
    Psychiatr Serv; 2019 Feb; 70(2):143-146. PubMed ID: 30526344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic exposure prior to acute myocardial infarction in patients with serious mental illness.
    Wu SI; Kao KL; Chen SC; Juang JJ; Lin CJ; Fang CK; Wu CS; Dewey M; Prince MJ; Stewart R
    Acta Psychiatr Scand; 2015 Mar; 131(3):213-22. PubMed ID: 25311084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.